Home > News > As the drug market moves to injectables, biotech majors strive to develop targeted-injection drugs for the treatment of a host of disorders
April 29th, 2007
Abstract:
Indian biotech majors, however, seem steady on their path. Dabur Pharma, for instance, achieved a breakthrough with its Nanoxel—a drug delivery system for the widely used anti-cancer drug Paclitaxel. This nanoscale drug delivery system is India's first indigenously developed nanotechnology-based chemotherapy agent, and also the first outside of the US. Positioned as a safer therapy for advanced breast, non-small-cell lung, and ovarian cancers, it enables therapy to take a preferential course to the cancerous cells and directly interact with the tumour-causing agents thereby throwing open a larger window for anti-tumour activity. It also ensures that the patient receives the full measure of therapy while limiting the adverse side effects and toxicity affected by the drug. This would be a great advantage because the biggest challenge faced in cancer therapy is the incidence of severe side effects that the cancer patient has to encounter while undergoing chemotherapy.
Source:
financialexpress.com
Related News Press |
Nanomedicine
Diamond glitter: A play of colors with artificial DNA crystals May 17th, 2024
Advances in priming B cell immunity against HIV pave the way to future HIV vaccines, shows quartet of new studies May 17th, 2024
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Gene therapy relieves back pain, repairs damaged disc in mice: Study suggests nanocarriers loaded with DNA could replace opioids May 17th, 2024
Oscillating paramagnetic Meissner effect and Berezinskii-Kosterlitz-Thouless transition in cuprate superconductor May 17th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||